- Clinical Trials Arena
Join Our Newsletter - Get important industry news and analysis sent to your inbox – sign up to our e-Newsletter here
X

Regeneron’s antibody cocktail meets endpoints in Covid-19 trial

REGN-COV2 is a combination of two monoclonal antibodies. Credit: CDC on Unsplash.